Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard
Fierce Pharma
DECEMBER 13, 2022
Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard. aliu. Tue, 12/13/2022 - 20:12.
Sat.Dec 10, 2022 - Fri.Dec 16, 2022
328 
Here’s How Skilled Nursing Facilities Can Use Virtual Reality Too
MedCity News
DECEMBER 12, 2022
It may take some time to introduce VR into your skilled nursing facility, but it will be worth it for the physical, mental, and social benefit of your residents.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
The Boston Globe Names CCC a Top Place to Work for 2022
Copyright Clearance Center
DECEMBER 13, 2022
December 13, 20 22 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, has been named one of the Top Places to Work in Massachusetts in the 15 th annual employee-based survey project from The Boston Globe. CCC ranked #17, up from #33 last year, in the “ large companies ” category (organizations between 250-999 employees).
Four ways Biogen is tackling digital innovation in neurological disease
pharmaphorum
DECEMBER 11, 2022
Digital transformation in pharma is not a singular endeavour. It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. So, when a life sciences company embarks on a project of digital transformation or innovation, it’s really embarking on multiple projects that span the wide world of pharmaceutical operations.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
ASH: CSL, uniQure's gene therapy Hemgenix shows durable protection in hemophilia B
Fierce Pharma
DECEMBER 12, 2022
ASH: CSL, uniQure's gene therapy Hemgenix shows durable protection in hemophilia B. kdunleavy. Mon, 12/12/2022 - 14:25.
Female Board Members Are Good for Business
PharmExec
DECEMBER 14, 2022
Perspectives from a board member and an aspiring board member on how to increase the number of qualified women on boards.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
CSL closes on EU approval for haemophilia B gene therapy
pharmaphorum
DECEMBER 16, 2022
CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. The positive opinion for etranacogene dezaparvovec – which was approved as Hemgenix by the FDA last month – raises the prospect of the first one-time therapy in the EU for the bleeding disorder, which affects around 1 in 50,000 of the population, according to the European Haemophilia Network (EUHANET).
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
DECEMBER 15, 2022
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access. zbecker. Thu, 12/15/2022 - 10:51.
First patient given base-edited CAR T cells
European Pharmaceutical Review
DECEMBER 12, 2022
A thirteen-year-old patient with relapsed T-cell acute lymphoblastic leukaemia (T-ALL) has been the first to be treated with base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy, which enabled them to achieve remission 28 days later. . A unique clinical trial for T-ALL. The patient enrolled in the ongoing clinical trial ( NCT05397184 ) went on to receive a second bone marrow transplant after the therapy.
Health Equity and the Push to Value-Based Care
MedCity News
DECEMBER 14, 2022
To effectively reduce disparities and improve the quality and coordination of care, government, providers, and healthcare organizations are beginning to collaborate on how to best address the factors driving gaps between populations.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Competition is on the horizon for costly narcolepsy treatments
pharmaphorum
DECEMBER 14, 2022
People who live with narcolepsy — about one out of every 2,000 Americans — don’t have many options when it comes to treatment. The milder form of narcolepsy includes symptoms of excessive daytime sleepiness and can be treated with a stimulant like Provigil, Adderall, or Dexedrine in order to get people through their day. In addition to excessive daytime sleepiness, up to 60% of narcolepsy cases include cataplexy, which is a sudden loss of muscle control.
Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'
Fierce Pharma
DECEMBER 14, 2022
Senators blast Pfizer's proposed COVID vaccine price hike as 'profiteering'. fkansteiner. Wed, 12/14/2022 - 09:00.
mRNA vaccine plus KEYTRUDA® improve melanoma survival
European Pharmaceutical Review
DECEMBER 14, 2022
Moderna, Inc. and Merck have announced that a Phase IIb trial ( NCT03897881 ) of a personalised mRNA cancer vaccine (mRNA-4157/V940), in combination with KEYTRUDA ® , Merck’s anti-PD-1 therapy, demonstrated the first randomised evidence that a personalised neoantigen approach may be beneficial in treating melanoma. Adjuvant treatment with mRNA-4157/V940 in combination with KEYTRUDA ® reduced the risk of recurrence or death by 44 percent (HR=0.56 [95 percent CI, 0.31-1.08]; one-sided p-valu
How L&D in Regulated Industries Can Move Beyond Just Compliance to Impact [Sponsored]
MedCity News
DECEMBER 12, 2022
The Covid-19 pandemic has forced life sciences companies to take a fresh look at how they do business. But as they reinvent their operations, companies often overlook a critical function: Their learning and development programs.
Inizio acquires Evolution Road
PharmExec
DECEMBER 12, 2022
The move bolsters Evoke’s digital innovation and omnichannel offering.
Watch out, Amgen. Mirati kicks off KRAS showdown with FDA approval for Krazati
Fierce Pharma
DECEMBER 12, 2022
Watch out, Amgen. Mirati kicks off KRAS showdown with FDA approval for Krazati. aliu. Mon, 12/12/2022 - 18:14.
Pharmacists migration to Australia and New Zealand gets easier now with Academically.ai
Pharmatutor
DECEMBER 10, 2022
Pharmacists migration to Australia and New Zealand gets easier now with Academically.ai. admin. Sat, 12/10/2022 - 15:42. Academically.ai, We are an Australian healthcare education technology (EdTech) start-up based in Sydney. We provide courses that will prepare pharmacists to practice, getting a job and migrate to Australia and New Zealand. To put it simply, we intend to enter the Indian market because the majority of pharmacists are underpaid, and many are unaware of such vast potential outsid
The White House Wants To Prevent Obesity, but We Also Need To Treat It
MedCity News
DECEMBER 14, 2022
Prevention is critical, and the ideas put forth in the White House’s proposal will likely help many Americans—particularly children—avoid weight gain as well as the downstream effects of obesity and its comorbidities. But more than 42% of U.S. adults already have obesity, and they need help now.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Medgadget Visits Healthcare? Expo Taiwan
Medgadget
DECEMBER 16, 2022
This past week, Medgadget was an official media partner with the Healthcareᐩ Expo Taiwan. This four-day annual event brings together healthcare companies from all over Taiwan and the rest of the world. It is also an opportunity for tech companies not typically associated with healthcare, such as ASUS, Intel, and BenQ, to showcase what they’re doing in medicine and healthcare.
AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer
Fierce Pharma
DECEMBER 15, 2022
AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer. kdunleavy. Thu, 12/15/2022 - 09:53.
Can pharma quit Twitter? Social strategy evolves as Musk changes the platform
PharmaVoice
DECEMBER 16, 2022
A breakdown of how Twitter’s recent shifts are impacting pharma, and how the industry should navigate the platform in 2023.
Most Health Systems Are Deploying Home-Based Care to Reduce Hospitalizations & ED Visits, Report Shows
MedCity News
DECEMBER 13, 2022
The majority of health systems now offer some sort of home-based care program, according to a new survey of hospital leaders. The biggest goals of these programs are to improve patient outcomes through reductions in readmissions, hospitalizations and emergency room visits, the report found.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
NICE backs use of Boehringer’s Ofev in IPF from diagnosis
pharmaphorum
DECEMBER 15, 2022
Thousands more UK patients with idiopathic pulmonary fibrosis (IPF) will now be eligible for treatment with Boehringer Ingelheim’s Ofev, following new guidance from health technology assessment agency NICE. Ofev (nintedanib) has been recommended since 2015 for NHS use in IPF patients who have a forced vital capacity (FVC) value of 50% to 80% of normal, but will now be an option for people with less severe disease, i.e. an FVC of more than 80%.
Novartis, busy with its restructuring, sells 5 eye drugs for up to $175M
Fierce Pharma
DECEMBER 14, 2022
Novartis, busy with its restructuring, sells 5 eye drugs for up to $175M. zbecker. Wed, 12/14/2022 - 11:22.
Utrogestan accepted as HRT in Scotland
European Pharmaceutical Review
DECEMBER 12, 2022
The Scottish Medicines Consortium (SMC) has accepted Utrogestan, the only adjunctive micronised progesterone available as hormone replacement therapy (HRT) for use alongside any oestrogen-only HRT for women with an intact uterus. Utrogestan 100mg, a product by Besins Healthcare UK, is a body-identical hormone, which means it has the same molecular structure as the hormone produced by the body.
Brightside Health Unveils New Program To Battle Suicide Epidemic
MedCity News
DECEMBER 14, 2022
Brightside Health has launched a new program called Crisis Care, specifically designed for individuals with elevated suicide risk. It is initially rolling out in 27 states, with plans to expand across the nation.
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Health virtual reality startups BehaVR and OxfordVR merge
pharmaphorum
DECEMBER 14, 2022
Two virtual reality startups operating in the health category – BehaVR and OxfordVR – have agreed to pool their efforts on the development of digital therapeutics (DTx) for mental illnesses via a merger. The combined company will operate under the BehaVR brand, and starts operations with a $13 million cash injection from a Series B financing led by Oxford Science Enterprises and Optum Ventures with participation from Confluent Health, Accenture Ventures, Chrysalis Ventures, and Thornton Capital.
Court swats down Vanda's patent suit against Teva and Apotex, clearing the way for Hetlioz generics
Fierce Pharma
DECEMBER 14, 2022
Court swats down Vanda's patent suit against Teva and Apotex, clearing the way for Hetlioz generics. kdunleavy. Wed, 12/14/2022 - 13:54.
The pharma giants making the biggest strides with global drug access
PharmaVoice
DECEMBER 12, 2022
A recent report ranks the top 20 pharma companies by how well they’re boosting a critical component of health equity.
4 KPIs That Providers Need To Know To Improve Value-based Care
MedCity News
DECEMBER 14, 2022
Here are four must-know key performance indicators that providers should know and use when looking to improve outcomes and the patient experience.
Let's personalize your content